MRNS Stock Summary and Trading Ideas (Marinus Pharmaceuticals | NASDAQ:MRNS)

Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.

Marinus Pharmaceuticals trades on the NASDAQ stock market under the symbol MRNS.

As of January 30, 2025, MRNS stock price was flat at $0.54 with 1,770,428 million shares trading.

MRNS has a beta of 6.59, meaning it tends to be more sensitive to market movements. MRNS has a correlation of 0.12 to the broad based SPY ETF.

MRNS has a market cap of $29.83 million. This is considered a Sub-Micro Cap stock.

Last quarter Marinus Pharmaceuticals reported $9 million in Revenue and -$.42 earnings per share. This fell short of revenue expectation by $-877,000 and missed earnings estimates by -$.01.

In the last 3 years, MRNS traded as high as $12.37 and as low as $.22.

The top ETF exchange traded funds that MRNS belongs to (by Net Assets): VTI, VXF, IWC, ITOT.

MRNS has underperformed the market in the last year with a price return of -94.7% while the SPY ETF gained +24.6%. However, in the short term, MRNS had mixed performance relative to the market. It has outperformed in the last 3 months, returning +86.4% vs +4.3% return in SPY. But in the last 2 weeks, MRNS shares have been beat by the market, returning -0.2% compared to an SPY return of +2.1%.

MRNS support price is $.53 and resistance is $.56 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MRNS shares will trade within this expected range on the day.